The Biollagen suite of products designed for use in skin care and medical procedures is derived from synthetic Pichia yeast.
The patented process produces a non-allergic high-performance vegan-accredited collagen, with 200 times the performance levels of collagen extracted from bovine gristle.
A study to determine the efficacy of Biollagen in skin care applications was conducted with a half-face assessment of two formulations, one containing a novel collagen (INCI name: sh-polypeptide-123, Trade Name: Biollagen) from JLand Biotech Ltd and a placebo formulation, in a panel of female volunteers with signs of premature facial ageing. Thirty-six (36) female volunteers age range 35 to 65 years were screened for the study, with 32 volunteers entering the study.
Materials and methods
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
